Sangui Bio Pty Ltd.

Alan Liddle

Ben Herbert

Elisabeth Karsten

Cameron Hill

The present disclosure relates to methods for modulating the level of proteins in a subject or in target cells by priming red blood cells with various agents or conditions that modulate the levels of proteins associated with red blood cells and administering the primed red blood cells to a subject. The disclosed methods represent a novel use of red blood cells primed to express a number of proteins, as cell therapies for numerous diseases or disorders.

Therapeutic methods using erythrocytes

The present disclosure relates to methods for generating blood protein profiles in red blood cell-enriched blood samples. The disclosed methods represent a new and improved laboratory technique for producing a protein profile from blood, increasing protein detection.

Growing community of inventors

Manly, Australia

Alan Liddle